Gene · 4036
Papers3,623
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,623
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-Resolution Genomic Profiling of Liver Cancer Links Etiology With Mutation and Epigenetic Signatures. | Cell Mol Gastroenterol Hepatol | 2023 | 36965814 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the role of cell heterogeneity in the sex difference in primary hyperparathyroidism. | Front Endocrinol (Lausanne) | 2023 | 36960393 | PubTator, text mining | PubMed |
| Still finding ways to augment the existing management of acute and chronic kidney diseases with targeted gene and cell therapies: Opportunities and hurdles. | Front Med (Lausanne) | 2023 | 36960337 | PubTator, text mining | PubMed |
| Regulated cell death pathways in kidney disease. | Nat Rev Nephrol | 2023 | 36959481 | PubTator, text mining | PubMed |
| Cross-ancestry, cell-type-informed atlas of gene, isoform, and splicing regulation in the developing human brain. | medRxiv | 2023 | 36945630 | PubTator, text mining | PubMed |
| ATP/ADP biosensor organoids for drug nephrotoxicity assessment. | Front Cell Dev Biol | 2023 | 36936695 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cell-Based Modeling of Single-Ventricle Congenital Heart Diseases. | Curr Cardiol Rep | 2023 | 36930454 | PubTator, text mining | PubMed |
| The specific phagocytosis regulators could predict recurrence and therapeutic effect in thyroid cancer: A study based on bioinformatics analysis. | Medicine (Baltimore) | 2023 | 36930113 | PubTator, text mining | PubMed |
| Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans. | Front Endocrinol (Lausanne) | 2023 | 36926036 | PubTator, text mining | PubMed |
| Adverse Events and Drug Resistance in Critically Ill Patients Treated with Colistimethate Sodium: A Review of the Literature. | Infect Drug Resist | 2023 | 36925725 | PubTator, text mining | PubMed |
| Angiotensin II type 2 receptor activation preserves megalin in the kidney and prevents proteinuria in high salt diet fed rats. | Sci Rep | 2023 | 36922642 | PubTator, text mining | PubMed |
| Interaction network of extracellular vesicles building universal analysis via eye tears: iNEBULA. | Sci Adv | 2023 | 36921051 | PubTator, text mining | PubMed |
| Vitamin D Deficiency Prevalence in Hospitalized Patients with COVID-19 Significantly Decreased during the Pandemic in Slovakia from 2020 to 2022 Which Was Associated with Decreasing Mortality. | Nutrients | 2023 | 36904131 | PubTator, text mining | PubMed |
| Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments? | J Clin Med | 2023 | 36902850 | PubTator, text mining | PubMed |
| Latest Knowledge on the Role of Vitamin D in Hypertension. | Int J Mol Sci | 2023 | 36902110 | PubTator, text mining | PubMed |
| Dissection of tumor antigens and immune landscape in clear cell renal cell carcinoma: Preconditions for development and precision medicine of mRNA vaccine. | Math Biosci Eng | 2023 | 36899527 | PubTator, text mining | PubMed |
| DICER1 RNase IIIb domain mutations trigger widespread miRNA dysregulation and MAPK activation in pediatric thyroid cancer. | Front Endocrinol (Lausanne) | 2023 | 36896180 | PubTator, text mining | PubMed |
| Mechanistic Insight into the role of Vitamin D and Zinc in Modulating Immunity Against COVID-19: A View from an Immunological Standpoint. | Biol Trace Elem Res | 2023 | 36890344 | PubTator, text mining | PubMed |
| Imputation-powered whole-exome analysis identifies genes associated with kidney function and disease in the UK Biobank. | Nat Commun | 2023 | 36890159 | PubTator, text mining | PubMed |
| Regulation of Prostate Androgens by Megalin and 25-hydroxyvitamin D Status: Mechanism for High Prostate Androgens in African American Men. | Cancer Res Commun | 2023 | 36875158 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4036/papers?page=24